{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:55:13Z","timestamp":1792688113126,"version":"4.5.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.msard.2022.103884","type":"journal-article","created":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T01:25:58Z","timestamp":1652577958000},"page":"103884","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Prevalence, incidence, and season distribution of MOG antibody-associated disease in the province of Verona, Italy"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3375-4098","authenticated-orcid":false,"given":"Riccardo","family":"Orlandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Mariotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Gajofatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2022.103884_bib0001","doi-asserted-by":"crossref","DOI":"10.1177\/1756286420945135","article-title":"Recent developments in MOG-IgG associated neurological disorders","volume":"13","author":"Hegen","year":"2020","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"3","key":"10.1016\/j.msard.2022.103884_bib0002","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1474-4422(18)30443-5","article-title":"Global, regional, and national burden of multiple sclerosis 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Wallin","year":"2019","journal-title":"Lancet Neurol."},{"issue":"June","key":"10.1016\/j.msard.2022.103884_bib0003","first-page":"1","article-title":"Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide","volume":"11","author":"Hor","year":"2020","journal-title":"Front. Neurol."},{"issue":"12","key":"10.1016\/j.msard.2022.103884_bib0005","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1007\/s00415-017-8635-4","article-title":"Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study","volume":"264","author":"Mariotto","year":"2017","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2022.103884_bib0006","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-018-1144-2","article-title":"MOG encephalomyelitis: international recommendations on diagnosis and antibody testing","volume":"15","author":"Jarius","year":"2018","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.msard.2022.103884_bib0004","doi-asserted-by":"crossref","unstructured":"Harding, K., Tilling, K., MacIver, C. et\u00a0al. Mark Willis, Fady Joseph, Gillian Ingram, Claire Hirst, et\u00a0al. 2017. Seasonal variation in multiple sclerosis relapse. J. Neurol. 264 (6): 1059\u201367. https:\/\/doi.org\/10.1007\/s00415-017-8485-0.","DOI":"10.1007\/s00415-017-8485-0"},{"key":"10.1016\/j.msard.2022.103884_bib0007","unstructured":"Resident population on 1st January\u00a0: Veneto. Accessed October 21, 2021. http:\/\/dati.istat.it\/Index.aspx?lang=en&SubSessionId=861b9ce4-c792-4fcd-904e-785201490dc4."},{"key":"10.1016\/j.msard.2022.103884_bib0008","first-page":"128","article-title":"Eurostat methodologies and working papers. Revision of the European standard population","year":"2013","journal-title":"Report of Eurostat's task force"},{"issue":"10","key":"10.1016\/j.msard.2022.103884_bib0009","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1136\/jnnp-2020-323158","article-title":"Prevalence and incidence of neuromyelitis optica spectrum disorder, aquaporin-4 antibody-positive NMOSD and MOG antibody-positive disease in Oxfordshire, UK","volume":"91","author":"O'Connell","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.msard.2022.103884_bib0010","first-page":"160","article-title":"The epidemiology of myelin oligodendrocyte glycoprotein antibody associated disorders","volume":"25","author":"Flanagan","year":"2019","journal-title":"Mult. Scler."},{"issue":"3","key":"10.1016\/j.msard.2022.103884_bib0011","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10072-016-2801-9","article-title":"Estimated prevalence of multiple sclerosis in Italy in 2015","volume":"38","author":"Battaglia","year":"2017","journal-title":"Neurol. Sci."},{"issue":"4","key":"10.1016\/j.msard.2022.103884_bib0012","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/ene.12045","article-title":"Prevalence of multiple sclerosis in Verona, Italy: an epidemiological and genetic study","volume":"20","author":"Gajofatto","year":"2013","journal-title":"Eur. J. Neurol."},{"issue":"14","key":"10.1016\/j.msard.2022.103884_bib0013","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1177\/1352458517735191","article-title":"Epidemiology of NMOSD in Catalonia: influence of the new 2015 criteria in incidence and prevalence estimates","volume":"24","author":"Sep\u00falveda","year":"2018","journal-title":"Mult. Scler."},{"issue":"7","key":"10.1016\/j.msard.2022.103884_bib0014","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1177\/1352458519845112","article-title":"The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults","volume":"26","author":"de Mol","year":"2020","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2022.103884_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577431","article-title":"Seasonal variation of onset in patients with anti-aquaporin-4 antibodies and anti-myelin oligodendrocyte glycoprotein antibody","volume":"349","author":"Akaishi","year":"2020","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.msard.2022.103884_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116881","article-title":"Seasonal distribution of attacks in aquaporin-4 antibody disease and myelin-oligodendrocyte antibody disease","volume":"415","author":"dos Passos","year":"2020","journal-title":"J. Neurol. Sci."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822003960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822003960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:01:53Z","timestamp":1761901313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034822003960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":16,"alternative-id":["S2211034822003960"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2022.103884","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence, incidence, and season distribution of MOG antibody-associated disease in the province of Verona, Italy","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2022.103884","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103884"}}